$30m for genetic medicine advancements
Eligo Bioscience secures $30m in series B funding, advancing its innovative gene-editing solutions targeting diseases linked to bacterial genes within the human microbiome.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1300 entries already.
Entries by Thomas Gabrielczyk
Takeover in ADC space: Abbvie snags ImmunoGen
/in News/by Thomas GabrielczykAbbVie buys ImmunoGen in US$10 billion deal, gains access to ADC for ovarian cancer. The ADC space gets hotter and hotter.
AI protein specialist Cradle raises US$24m in Series A financing
/in News/by Thomas GabrielczykGenerative AI protein engineering specialist Cradle NV, has raised US$24m in a Series A financing round led by Index Ventures w
Repairing MS-caused damage with stem cells
/in News/by Thomas GabrielczykBritish and Italian researchers have demostrated promising results in patients with progressive multiple sclerosis through stem cell transplantation into the brain.
Novo Nordisk invests €2.1bn in production expansion
/in News/by Thomas GabrielczykIn the race for global market share of its obesity and diabetes blockbuster semaglutide, Novo Nordisk is expanding production in Europe.<br /><br /><br />
Quotient Therapeutics kicks-off with US$50m financing
/in News/by Thomas GabrielczykFlagship Pioneering has committed US$50m to launch Quotient Therapeutics that links genetic variation at cellular level with disease by Nanoseq, a sequencing method licenced from the Wellcome Sanger Institute.
Solar Foods raises €8m in Series B financing
/in News/by Thomas GabrielczykFinnish protein maker Solar Foods has closed an oversubscribed €8M Series B financing and will expand Solein protein production and support the construction of a commercial production plant.
Germany boosts protein transition with €38m
/in News/by Thomas GabrielczykThe Budget Committee of the German Bundestag has announced to channel €38m in funding into the sustainable protein transition next year.<br /><br />
Microharvest GmbH launches SCP-Pilot plant in Lissabon
/in News/by Thomas GabrielczykGerman precision fermentation specialist MicroHarvest GmbH has launched a single-cell protein pilot plant in Lison with an initial capacity of 25kg per day.
AMR: Partnership set to improve in vivo antibiotics testing
/in News/by Thomas GabrielczykThe Innovative Medicine Initiative 2 JU-funded €25m project COMBINE is joining forces with CARB-X & CAIRD, iiCON and Pharmacology Discovery Services to improve in vivo antibiotics testing.